OTCMKTS:KHRNF Khiron Life Sciences (KHRNF) Stock Forecast, Price & News $0.01 0.00 (-14.63%) (As of 10/2/2023 ET) Add Compare Share Share Today's Range$0.0105▼$0.012050-Day Range$0.0104▼$0.017052-Week Range$0.01▼$0.13Volume59,587 shsAverage Volume199,073 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsHeadlinesShort InterestProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest About Khiron Life Sciences (OTCMKTS:KHRNF) StockKhiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.Read More KHRNF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KHRNF Stock News HeadlinesOctober 3, 2023 | americanbankingnews.comKhiron Life Sciences Corp. (OTCMKTS:KHRNF) Sees Significant Decrease in Short InterestJuly 11, 2023 | msn.comCannabis Stock Gainers And Losers From July 11, 2023October 3, 2023 | Wall Street Fundamentals (Ad)The "Plug and Play" Model Putting Online Giants to ShameWhile e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."June 19, 2023 | sg.finance.yahoo.comKHRNF - Khiron Life Sciences Corp.June 5, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron Life Sciences Agrees to $500,000 Secured DepositJune 5, 2023 | finance.yahoo.comKhiron Life Sciences Agrees to $500,000 Secured DepositMay 6, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDERApril 20, 2023 | finance.yahoo.comKhiron Completes First Phase of Business OptimizationOctober 3, 2023 | Wall Street Fundamentals (Ad)The "Plug and Play" Model Putting Online Giants to ShameWhile e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."April 17, 2023 | msn.comKhiron Life Sciences CFO Helen Bellwood to be replaced by Michael O'ConnorApril 17, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES NEW CFOApril 17, 2023 | finance.yahoo.comTake Care Before Jumping Onto Khiron Life Sciences Corp. (CVE:KHRN) Even Though It's 47% CheaperApril 12, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT down on Monday (KHRN-WT)March 24, 2023 | benzinga.comKhiron Stock Trading Lower On Announcing Pricing Of Marketed Offering Of UnitsMarch 24, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES PRICING OF MARKETED OFFERING OF UNITSMarch 16, 2023 | marketwatch.comKhiron Life Sciences Shares Drop 28% on Overnight OfferingFebruary 17, 2023 | seekingalpha.comKHRNF Khiron Life Sciences Corp.February 16, 2023 | finance.yahoo.comKhiron Closes Additional Loan with Investment-Grade BankFebruary 14, 2023 | finance.yahoo.comKhiron Closes Revolving Credit Facility with Financing Company in ColombiaJanuary 18, 2023 | proactiveinvestors.comKhiron Life Sciences shares growth in medical cannabis field throughout South America and EuropeJanuary 9, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron wins first medical cannabis contract with Colombia's largest public insurance companyDecember 1, 2022 | finance.yahoo.comKhiron Life Sciences Third Quarter 2022 Earnings: CA$0.017 loss per share (vs CA$0.019 loss in 3Q 2021)November 30, 2022 | seekingalpha.comKhiron Life Sciences Corp. (KHRNF) Q3 2022 Earnings Call TranscriptNovember 30, 2022 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron Life Sciences Reports Third Quarter 2022 Financial ResultsNovember 30, 2022 | finance.yahoo.comKhiron Life Sciences Reports Third Quarter 2022 Financial ResultsNovember 18, 2022 | finance.yahoo.comKhiron to Host Third Quarter 2022 Conference Call on November 30, 2022November 16, 2022 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United KingdomSee More Headlines Receive KHRNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address KHRNF Company Calendar Today10/03/2023Next Earnings (Estimated)11/28/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers—Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:KHRNF CUSIPN/A CIKN/A Webwww.khiron.ca Phone(702) 527-3564FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Alvaro Francisco Torres (Age 44)Co-Founder, CEO & Director Comp: $201.6kMs. Franziska KatterbachPres of Khiron EuropeMr. Swapan Kakumanu ACA (Age 53)ACWA, CGA, Corp. Sec. Comp: $44.32kMr. Michael John O'Connor MA (Age 56)Chief Financial Officer Mr. Manuel BuendiaVP of OperationsMr. Marco AlgortaCountry Mang. of UruguayMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbattis BioceuticalsOTCMKTS:ATTBFView All Competitors KHRNF Stock - Frequently Asked Questions Should I buy or sell Khiron Life Sciences stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" KHRNF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KHRNF, but not buy additional shares or sell existing shares. View KHRNF analyst ratings or view top-rated stocks. How have KHRNF shares performed in 2023? Khiron Life Sciences' stock was trading at $0.0415 on January 1st, 2023. Since then, KHRNF stock has decreased by 74.7% and is now trading at $0.0105. View the best growth stocks for 2023 here. Are investors shorting Khiron Life Sciences? Khiron Life Sciences saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 146,000 shares, a decline of 9.8% from the August 31st total of 161,900 shares. Based on an average trading volume of 336,300 shares, the days-to-cover ratio is currently 0.4 days. View Khiron Life Sciences' Short Interest. When is Khiron Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 28th 2023. View our KHRNF earnings forecast. What is Khiron Life Sciences' stock symbol? Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF." How do I buy shares of Khiron Life Sciences? Shares of KHRNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Khiron Life Sciences' stock price today? One share of KHRNF stock can currently be purchased for approximately $0.01. How can I contact Khiron Life Sciences? Khiron Life Sciences' mailing address is 500 Burrard Street, Vancouver, BC V6C. The official website for the company is www.khiron.ca. The company can be reached via phone at (702) 527-3564. This page (OTCMKTS:KHRNF) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Khiron Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.